ArticleBritish journal of pharmacology2015

Inhibition of breast cancer progression by a novel histone deacetylase inhibitor, LW479, by down-regulating EGFR expression.

Jingjie Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.